Maravai LifeSciences Holdings - Multiplikator EV/Sales MRVI

Logo perusahaan publik Maravai LifeSciences Holdings (MRVI)

The current price-to-sales ratio of Maravai LifeSciences (MRVI) correlates with the company's transition to eco-friendly reagents and green chemistry principles. The value of 9941.69 shows the latest metric reading, while the business relies on the automation of nucleic acid synthesis for vaccine development. Revenue stability is driven by CleanCap technology, which creates high switching costs for biopharmaceutical clients.

Maravai LifeSciences Corp (MRVI) - Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar Maravai LifeSciences Corp (MRVI)

- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:Maravai LifeSciences - MRVI
Produk asli Maravai LifeSciences Holdings

This indicator determines the market value of the business relative to sales volume, excluding the impact of debt load. The metric allows for an assessment of revenue generation efficiency without distortions caused by capital structure. By analyzing historical EV/Sales trends, an investor can identify whether an asset is overbought or possesses growth potential. For Maravai LifeSciences (MRVI), the stability of this ratio is supported by a robust audit of reagent suppliers. This ensures the continuity of medical analysis production and the predictability of cash flows.

Analisis pesaing Maravai LifeSciences

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan EXAS|Revvity, Inc. (RVTY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales BIO|NNNN (Anbio Biotechnology) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales SHC (Sotera Health)|Quidel Corporation (QDEL) - Multiplikator nilai perusahaan marang pendapatan|OPK - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan CareDx Corp CDNA|FLGT: Multiplikator EV/Sales|LAB (Standard BioTools Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Cytek Biosciences Inc|Multiplikator nilai perusahaan marang pendapatan OraSure OSUR|Nilai perusahaan marang pendapatan XGN (Exagen Diagnostics)|Rasio total nilai perusahaan marang pendapatan MDxHealth Inc.|Rasio nilai perusahaan marang pendapatan Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan